Inicio de la web del Complejo Hospitalario Universitario de Albacete

Saltar a contenidos
Salón de actos

Barra de navegación

Esta usted en:
  • Inicio
  • Departamento de Investigación

 

Compartir en FacebookCompartir en Twitter
Aumentar tamao del texto..
Tamao normal del texto..
Disminuir tamao del texto..
Escuche el contenido de esta pgina. Se abrir una nueva ventana..
Publicaciones.

Contenido


Relación de artículos publicados en los últimos años por personal
del Complejo Hospitalario Universitario de Albacete

 

2010 - 2011 - 2012- 2013- 2014

 

2015
Publicaciones por departamento 2015
Autores Artículo Revista FI* Cuartil
ATENCIÓN PRIMARIA
1 Párraga Martínez I, López-Torres Hidalgo J, del Campo del Campo JM, Galdón Blesa MP, Precioso Yáñez JC, Rabanales Sotos J, García-Reyes Ramos M, Ándrés Pretel F, Navarro Bravo B, lloret Callejo A. Efecto a largo plazo de los estanoles vegetales en el perfil lipídico de pacientes con hipercolesterolemia. Ensayo clínico aleatorizado. Revista Española de Cardiología, 2015. 68(8):665-671. 3.792 2
2 Rabanales Sotos J, López González A, Párraga Martínez I, Campos Rosa M, Simarro Herráez MJ, López-Torres Hidalgo J. SELF-ASSESSEMNT OF ALCOHOL CONSUMPTION AS A HEALTH-EDUCATION STRATEGY IN NURSING STUDENTS. Nurse Education Today. 2015; 35:132-37. 1.364 1
3 Rabanales Sotos J, López González A, Párraga Martínez I, Campos Rosa M, Simarro Herráez MJ, López-Torres Hidalgo J. Prevalence of hazardous drinking among nursing students. Journal of Advanced Nursing, 2015; 71(3):581-90 1.741 1
4 López-Torres J, Rabanales J, Simarro MJ y PITES-ALBACETE Group. Effectiveness of a telemedicine programme for patients with metabolic syndrome. Technology and Health Care, 2015. 23(2):161-169. 0,697 4
5 García Alcaraz F, Delicado Useros V, Alfaro Espín A, López-Torres Hidalgo J Utilización de recursos sociosanitarios y características del cuidado informal de los pacientes inmovilizados en atención domiciliaria. Atención Primaria. 2015;47(4):195-204. 0,957 3
6 García Atienza EM, Llanos Val Jiménez C, Navarro Ruiz S, López-Torres Hidalgo J. Mesotelioma pleural maligno. Medicina Paliativa (en prensa).
7 López-Torres Hidalgo J, López Gallardo Y, Párraga Martínez I, del Campo del Campo JM, Villena Ferrer A, Morena Rayo S Treatment Satisfaction Among Patients Taking Antidepressant Medication. Community Mental Health Journal (in press). 1,111 3
8 Ayuso-Raya MC, Escobar-Rabadán F, López-Torres Hidalgo J, Montoya-Fernández J, Téllez-Lapeira JM, Campa Valera F Elección de Medicina Familiar en los exámenes para médicos residentes españoles de 2011 y 2013 Revista Médica del Instituto Mexicano del Seguro Social. 2015; 53(1):44-52
9 López-Torres J, Rabanales J, Fernández R, López FJ, Panadés Ll, Romero V. Resultados de un programa de telemedicina para pacientes con diabetes tipo 2 en atención primaria Gaceta Sanitaria. 2015; 29(1):55-8 1,186 3
10 Pérez Morote ML, López-Torres Hidalgo J, López Verdejo MA Características sociosanitarias de los pacientes en incapacidad temporal en el área sanitaria de Albacete Medicina y Seguridad del Trabajo (Internet) 2015; 61(238):45-56.
11 Pérez Morote ML, López-Torres Hidalgo J, López Verdejo MA Análisis de las variables sociosanitarias asociadas a la permanencia en incapacidad temporal. Medicina y Seguridad del Trabajo (Internet) 2015; 61(239): 184-194.
12 López-Torres JD. Sánchez MO, Rabanales J, Simarro MJ, López-Torres J, Campos M Effectiveness of three interventions to improve adherence to cervical cancer screening. European Journal of Cancer Prevention (in press) 3,031 2
13 López-Torres Hidalgo J Pagar por publicar” en revistas científicas. Revista Clínica de Medicina de Familia. 2015; 8(3): 179-181.
14 López-Torres Hidalgo J, Rabanales Sotos J, Simarro Herráez MJ, Campos Rosa M, López-Torres López J, Sánchez Ortiz MP Factors Associated With Cancer Worry Among People Aged 50 or Older, Spain, 2012–2014 Preventing Chronic Disease (in press) 2,123 2
15 Ignacio Párraga-Martínez, Joseba Rabanales-Sotos, Fernando Lago-Deibe, Juan M Téllez-Lapeira, Francisco Escobar-Rabadán, Alejandro Villena-Ferrer, Mariano Blasco-Valle, José M Ferreras-Amez, Susana Morena-Rayo, José M del Campo-del Campo, Maria Candelaria Ayuso-Raya, José J Pérez-Pascual. Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomized clinical trial. BMC Cardiovascular Disorders. 2015, 15:8 1,457 3
16 Aragonès E, López-Rodríguez JA, Escobar-Rabadán F, Téllez-Lapeira J, Mínguez J, Párraga I, Suárez-Hernández T, Piñero MJ, Guzón MM; el Grupo de Investigación en Trastorno Bipolar y Atención Primaria. Cribado para el trastorno bipolar en pacientes de atención primaria que presentan síntomas psicológicos. Aten Primaria. 2015; 47(3):167-74. 0,894 3
17 Artigao-Ródenas LM, Carbayo-Herencia JA, Palazón-Bru A, Divisón-Garrote JA, Sanchís-Doméneck C, Vigo-Aguiar I y Gil-Gillén VF Construction and validation of a 14 year cardiovascular risk score for use in the general population: the Puras-GEVA Chart Medicine; 2015; 94(47):1-8 5,723 1
18 Ponce-García I, Simarro Rueda M, Carbayo-Herencia JA, Divisón Garrote JA, Artigao-Ródenas LM, Botella-Romero F, Palazón-Bru A, Martínez-St. John DRJ, Gil-Guillén VFy GEVA Prognostic value of obesity on both overall mortality and cardiovascular disease in the general population PLOS one, 2015 3,234 1
ENDOCRINOLOGÍA Y NUTRICIÓN
1 Currás M, Inglada L, Mancikova V, Montero C, LÑetón R, Comino I, Apellániz M, Sánchez L, Aguirre M, Alcázar V, Aller J, Álvarez C, Andía VM; Azriel S, Calatayud M, Díaz JA, Díez A, Lamas C, Marazuela M, Matías X, Meoro A, Patiño A, Pedrinaci S, Riesco G, Sábado C, Sáez R, Sainz A, Sanz O, Sastre J, Scolá B, Segura A, Serrano MS, Villar MR, Rodríguez C, Korpershoek E, Cascón A, Robledo M Recommendations for somatic and germline genetic testing of single pheochromocytoma andparaganglioma based on findings from a series of 329 patients J Med Genet 2015; 52(10):647-56 6,335 1
2 S. Vilar, C. Lamas, M.A. Fagundez, A.T. Núñez, A. Pérez, J. Merayo, J.J. Escobar, J.M. Rico. Orbitopatía tiroidea, una visión global con atención especial al papel de la radioterapia Endocrinología y Nutrición 2015; 62(4): 188-199
3 N. Valdés, E. Navarro, J. Mesa, A. Casteras, V. Alcazar, C. Lamas, J. Tébar, L. Castaño, S. Gaztambide, L. Forga RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation European Journal of Endocrinology 2015; 172:301–307 4,069 2
4 C. Lamas, C. del Pozo y C. Villabona, en representación del Grupo de Neuroendocrinología de la SEEN Guía clínica de manejo de la diabetes insípida y del síndrome de secreción inapropiada de hormona antidiurética en el postoperatorio de la cirugía hipo?saria Endocrinología y Nutrición 2014; 61(4): e15-e24.
5 Olveira G, Tapia MJ, Ocón J, Cabrejas-Gómez C, Ballesteros-Pomar MD, Vidal-Casariego A, Arraiza-Irigoyen C, Olivares J, Conde-García MC, García-Manzanares A, Botella-Romero F, Quílez-Toboso RP, Cabrerizo L, Matía P, Chicharro L, Burgos R, Pujante P, Ferrer M, Zugasti A, Petrina E, Manjón L, Diéguez M, Carrera MJ, Vila-Bundo A, Urgelés JR, Aragón-Valera C, Sánchez-Vilar O, Bretón I, García-Peris P, Muñoz-Garach A, Márquez E, Del Olmo D, Pereira JL, Tous MC. Prevalence of Diabetes, Prediabetes and Stress Hyperglycemia, Insulin Therapy and Metabolic Control in Patients on Total Parenteral Nutrition (Prospective Multicenter Study) Endocr Pract. 2015 Jan;21(1):59-67. 2,327 3
6 Nutrition Area of the Spanish Society of Endocrinology and Nutrition Hypoglycemia in noncritically ill patients receiving total parenteral nutrition (multicenter study). Study Group of Hyperglycemia in Parenteral Nutrition Nutrition 31 (2015) 58-63. 2,926 2
7 Tapia MJ, Ocón J, Cabrejas-Gómez C, et al. Study group of hyperglycemia in parenteral nutrition. Nutrition area of the spanish society of endocrinology and nutrition Nutrition-related risk indexes and long-term mortality in noncritically ill inpatients who receive total parenteral nutrition (prospective multicenter study). Clinical Nutrition 2015 Oct;34(5):962-7. 4,476 1
8 Botella F, Alfaro JJ, Hernández A. Uso y abuso de la sal en la alimentación humana. Nutrición Clínica en Medicina 2016. 9(3) 189-203.
GERIATRÍA
1 Abizanda P, López MD, García VP, Estrella JD, da Silva González Á, Vilardell NB, Torres KA. Effects of an Oral Nutritional Supplementation Plus Physical Exercise Intervention on the Physical Function, Nutritional Status, and Quality of Life in Frail Institutionalized Older Adults: The ACTIVNES Study. J Am Med Dir Assoc 2015; 16: 439.e9-439.e16. 4,939 1
2 Abizanda P, Romero L, Sánchez-Jurado PM, Flores-Ruano T, Salmerón-Ríos S, Fernández-Sánchez M. Energetics of aging and frailty: The FRADEA Study. J Gerontol A Biol Sci Med Sci 2015. Oct 13. pii: glv182. 5,416 1
3 Salmerón S, Huedo I, López-Utiel M, Soler-Moratalla I, Flores-Ruano T, Fernández-Sánchez M, Noguerón A, Doody RS, Abizanda P. Validation of the Spanish Version of the Baylor Profound Mental Status Examination. J Alzheimers Dis 2015; 49: 73-8. 4,151 1
4 Abizanda P, Diez-López M, Pérez-García V, de Dios Estrella J, da Silva-González Á, Barcons-Vilardell N, Araujo-Torres K. Response to the Letter by Canbaz et al. J Am Med Dir Assoc 2015; 16: 798. 4,939 1
5 Blanco-Reina E, Ariza-Zafra G, Ocaña-Riola R, León-Ortíz M, Bellido-Estévez I. Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related? Eur J Clin Pharmacol. 2015; 71: 199-207. 2,966 2
NEFROLOGÍA
1 Ortega A, Farah S, Tranque P, Ocaña AV, Nam-Cha SH, Beyth N,
Gómez-Roldán C, Pérez-Tanoira R, Domb AJ, Pérez-Martínez FC,
Pérez-Martínez J.
Antimicrobial evaluation of quaternary ammonium polyethyleneimine nanoparticles against clinical isolates of pathogenic bacteria. IET Nanobiotechnol. 2015 Dec;9(6):342-8. 1,5 3
2 Martínez Fernández G, Ortega Cerrato A, de la Vara Iniesta L, Oliver Galera E, Gómez Roldán C, Pérez Martínez J. Comparación entre bioimpedancia espectroscópica y fórmula de Watson para medición de volumen corporal en pacientes en diálisis peritoneal. Nefrologia 2015;12:20-26 1,212 3
NEUMOLOGÍA
1 Amaral AF1, Newson RB2, Abramson MJ3, Antó JM4, Bono R5, Corsico AG6, de Marco R7, Demoly P8, Forsberg B9, Gislason T10, Heinrich J11, Huerta I12, Janson C13, Jõgi R14, Kim JL15, Maldonado J16, Martinez-Moratalla Rovira J17, Neukirch C18, Nowak D19, Pin I20, Probst-Hensch N21, Raherison-Semjen C22, Svanes C23, Urrutia Landa I24, van Ree R25, Versteeg SA26, Weyler J27, Zock JP28, Burney PG29, Jarvis DL29. Changes in IgE sensitization and total IgE levels over 20 years of follow-up. J Allergy Clin Immunol. 2015 Nov 13. 11,476 1
2 Gerra S, Halonen M, Vasquez MM, Spangenberg A, Stern DA, Morgan WJ, Wright AL, Lavi I, Tarés L, Carsin AE, Dobaño C, Barreiro E, Zock JP, Martínez-Moratalla J, Urrutia I, Sunyer J, Keidel D, Imboden M, Probst-Hensch N, Hallberg J, Melén E, Wickman M, Bousquet J, Belgrave DCM, Simpson A, Custovic A, Antó JM, Martínez FD Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study The Lancet Respiratory Medicine, 2015; 3(8):613-620 9,629 1
3 Callejas González FJ, Genovés Crespo M, Cruz Ruiz J, Tornero Molina AI, Esquinas López C, Bermejo López P, García Castillo S, Martínez García AJ, Rodríguez Montes JA and Tárraga López PJ. Continuous Abstinence Rates at 3, 6, 9 and 12 Months in a Smoking Cessation Unit at the Albacete University Hospital Over 2 Years Int J Respir Pulm Med 2015, Vol 2, Issue 1.
4 Callejas González FJ, Genovés Crespo M, Cruz Ruiz J, Esquinas López C, Tárraga López PJ, Pablo Bermejo López, Tornero Molina AI, Pastrana Calderón J, Molina Cano A and Rodríguez Montes JA. A comparative study for successful treatment per gender in a Specialized Smoking Cessation Unit in the Albacete University Hospital during two years. Journal of Health Science 2015, Vol 3, Issue 3: 103-112.
5 Callejas González FJ, Genovés Crespo M, Bermejo López P, Tárraga López PJ, Cruz Ruiz J, Tornero Molina AI,
Rodríguez Montes JA Estudio de la estadística predictiva de los datos obtenidos en una consulta especializada de deshabituación tabáquica en el Complejo Hospitalario Universitario de Albacete durante dos años Prevención del Tabaquismo 2015; 17(2): 62-70
6 Callejas González FJ and Mayoris Almonte W Towards characterizing COPD exacerbations Insights in Allergy, Asthma and Bronchitis. November 30, 2015; 1 (2): 11.
NEUROLOGÍA
1 Sánchez-Larsen A, Feria-Vilar I, Collado R, Segura T. Collet-Sicard syndrome caused by metastasis. Neurología 2015; Nov 19 1,32 4
2 Pardal-Fernandez JM, Segura JC, Grande A, Segura T Guillain-Barre syndrome. Early ultrasound findings Rev Neurol. Nov 16;61(10):471 0,83 4
3 Lara L, Grande A, Pardal-Fernández JM, Segura T. The value of ultrasounds in the detection of lingual fasciculations] Rev Neurol. 2015 Nov 1;61(9):431. Spanish 0,83 4
4 Albiñana V, Villar Gómez de Las Heras K, Serrano-Heras G, Segura T, Perona-Moratalla AB, Mota-Pérez M, de Campos JM, Botella LM Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients Orphanet J Rare Dis. 2015 Sep 22;10(1):118
5 García-García J, Sánchez-Larsen Á, Díaz-Maroto I, Ayo-Martín Ó,Segura T Carotidynia, back to an old controversial issue Rev Neurol. 2015 May 16;60(10):473-4 0,83 4
6 Serena J, Segura T, Roquer J, García-Gil M, Castillo J; ARTICO Study. The ARTICO study: identification of patients at high risk of vascular recurrence after a first non-cardioembolic stroke. BMC Neurol. 2015 Mar 11;15:28
7 Monteagudo M, Doménech C, Segura T. Terson syndrome and ocular ultrasound. Neurologia. 2015 Mar;30(2):133-4 1,32 4
8 Sato S, Arima H, Heeley E, Hirakawa Y, Delcourt C, Lindley RI, Robinson T, Huang Y, Morgenstern L, Stapf C, Wang J, Chalmers J, Anderson CS; INTERACT2 Investigators. Off-Hour Admission and Outcomes in Patients with Acute Intracerebral Hemorrhage in the INTERACT2 Trial. Cerebrovasc Dis. 2015;40(3-4):114-20 3,754 1
9 Mar J, Masjuan J, Oliva-Moreno J, Gonzalez-Rojas N, Becerra V, Casado MÁ, Torres C, Yebenes M, Quintana M, Alvarez-Sabín J; CONOCES Investigators Group. Colaborators. Arenillas Lara JF, Martínez Zabaleta M, Álvarez-Amandi MR, Segura Martín T, Lago Martín A, Gállego Culleré J, López Gastón JI, Moniche Álvarez F, Jiménez MD, Castillo Sánchez J, Jiménez Martínez MC, López Fernández JC, Casado Naranjo I, González Rodríguez C, Escribano Soriano B. Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain. Health Qual Life Outcomes. 2015 Mar 17;13:36 2,12 2
10 Sánchez-Larsen A, Monteagudo M, Lozano-Setién E, García-García, J Neurocisticercosis racemosa subaracnoidea gigante y ventricular: a propósito de un caso Rev Argent Microbiol 2015; 47:201-5 0.8 4
11 Monteagudo M, Fernández-Díaz E, García-García J, Ayo-Martin O Hernández-Fernández F., Segura T Efficacy, safety and tolerability of rivaroxaban for the secondary prevention of stroke in patients with atrial fibrillation in clinical practice Future Neurol 2015. 10:515-527
12 García-García J, Roquer J, Serena J, Castillo J, Blanco M, Díaz-Maroto I, Segura T. Carotid intima-media thickness is not associated with markers of aterosclerosis in stroke patients Journal of Stroke and Cerebrovacular diseases 2016; in press 1.669 4
13 1. Arima H, Heeley E, Delcourt C, Hirakawa Y, Wang X, Woodward M, Robinson T, Stapf C, Parsons M, Lavados PM, Huang Y, Wang J, Chalmers J, Anderson CS; INTERACT2 Investigators Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2. Neurology. 2015 ;84:464-71 8,185 1
14 Espinosa de Rueda M, Parrilla G, Manzano-Fernández S, Garcia-Villalba B, Zamarro J, Hernández-Fernández F, Sánchez-Vizcaino C, Carreon E, Morales A, Moreno A. A Combined Multimodal CT Score Correlates With Futile Recanalization After Thrombectomy in Acute Stroke Patients Stroke 2015;46:2517-22 5,761 1
15 Lucas Pérez-Romero J, Hernández-Fernández F, Lucas Pérez-Romero M, González-Ramírez B. Cefalea pulsátil Rev Clin Med Fam 2015;8(1):66-70. 0,8 4
16 Tomás Segura, Francisco Hernández-Fernández y Jaime Masjuan Enfermedades del sistema nervioso (II). Otras enfermedades cerebrovasculares. Vasculopatías no arteriosclerosas. Trombosis venosa cerebral. Medicine. 2015;11(71):43-56 5,723 1
OFTALMOLOGÍA
1 Rojas J, Fernandez I, Pastor JC, MacLaren RE, Ramkissoon Y, Harsum S, Charteris DG, Van Meurs JC, Amarakoon S, Garcia-Arumi J, Ruiz-Moreno JM, Rocha-Sousa A, Brion M, Carracedo A; for the Genetics on PVR Study Group. Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables Br J Ophthalmol 2015;99:41-8. 2,976 1
2 A García-Layana, J García-Arumí, J M Ruiz-Moreno, L Arias, F Cabrera and M S. Figueroa. Review of Current Management of Vitreomacular Traction and Macular Hole Journal of Ophthalmology 2015; 1,425 3
3 Flores-Moreno I, Arias-Barquet L, Rubio-Caso MJ, Ruiz-Moreno JM, Duker JS, Caminal JM. En face swept-source optical coherence tomography in neovascular age-related macular degeneration. Br J Ophthalmol. 2015 2,976 1
4 Ruiz-Moreno JM. New perspectives in the approach to diabetic macular edema. Aflibercept therapy. Arch Soc Esp Oftalmol. 2015 Mar;90 Suppl 1:24-28.
5 Ruiz-Medrano J, Flores-Moreno I, Peña-García P, Montero JA, Duker JS, Ruiz-Moreno JM. ASYMMETRY IN MACULAR CHOROIDAL THICKNESS PROFILE BETWEEN BOTH EYES IN A HEALTHY POPULATION MEASURED BY SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY. Retina, 2015<, 35:2067-2073 3,243 1
6 Figueroa MS, Ruiz-Moreno JM, Gonzalez Del Valle F, Govetto A, de la Vega C, Plascencia RN, Contreras I, Medina JL. LONG-TERM OUTCOMES OF 23-GAUGE PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND GAS TAMPONADE FOR MYOPIC TRACTION MACULOPATHY: A Prospective Study. Retina, 2015; 35:1836-18433,243 3,243 1
7 Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Fernández I, García-Gutierrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon YD, Harsum S, MacLaren RE, Charteris DG, Van Meurs JC, González-Sarmiento R, Pastor JC; Genetics on PVR Study Group. BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the Retina 4 project. Acta Ophthalmol., 2015 2,844 1
8 Ruiz-Medrano J, Flores-Moreno I, Montero JA, Duker JS, Ruiz-Moreno JM. Morphological features of the choroidoscleral interface in a healthy population using Swept-source Optical Coherence Tomography. Am J Ophthalmol. 2015; 160: 596-601 3,871 1
9 Ruiz-Moreno JM, Montero JA, Araiz J, Arias L, García-Layana A, Carneiro A, Figueroa MS, Silva R. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: Six Years Outcome. Retina, 2015 3,243 1
10 Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Fernández I, García-Gutierrez
MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon YD, Harsum S, MacLaren RE,
Charteris DG, Van Meurs JC, González-Sarmiento R, Pastor JC;
Genetics on PVR
Study Group. BAX and BCL-2 polymorphisms, as predictors of proliferative
vitreoretinopathy development in patients suffering retinal detachment: the
Retina 4 project.
Acta Ophthalmol. 2015 May 19. [Epub ahead of print] 2,844 1
11 Yit Yang, Clare Bailey, Frank Holz, Nicole Eter, Michel Weber, Carl Baker, Szilárd Kiss, Ugo Menchini, Jose M Ruiz-Moreno, Pravin Dugel and Andrew Lotery. Long-term Outcomes of Phakic Patients With Diabetic Macular Oedema Treated With Intravitreal Fluocinolone Acetonide (FAc) Implants Eye (Lond). 2015 Sep;29(9):1173-80 2,082 2
12 Alfredo Adan, Marina Mesquida, Salvatore Di Lauro, Jose María Ruiz-Moreno, Ignacio Flores MD, Marta Fernandez, Alfredo Garcia Layana, Jose Carlos Pastor Role of systemic anti-tumor necrosis factor alpha treatment in the reduction of proliferative vitreoretinopathy Journal of Clinical & Experimental Ophthalmology, 2015
13 Alfredo García Layana, Marta S. Figueroa, Javier Araiz, José M. Ruiz -Moreno, Francisco Gómez-Ulla, Luis Arias Barquet Treatment of exudative age-related macular degeneration: focus on aflibercept Drugs Aging. 2015 Oct;32(10):797-807 2,838 2
14 Pablo Peña-García, Cristina Peris-Martínez, Alessandro Abbouda, José M. Ruiz-Moreno Detection of subclinical keratoconus through non contact tonometry and the use of discriminant biomechanical functions Journal of Biomechanics, 2015 2,751 2
15 Ignacio Flores-Moreno, Luis Arias-Barquet, María Vidal-Martí, Alex Muñoz-Blanco, Marcos J Rubio-Caso, José M Ruiz-Moreno, Jay S Duker, Josep M Caminal. Vitreomacular interface pathology prevalence in a Spanish tertiary hospital Ophtahlmologica, 2015 1,676 2
16 Balañá M, Ruiz-Moreno JM, Roura M; Study Group of Mypathway. National Study to Assess The Costs of Patients With High Myopia With and Without Choroidal Neovascularisation. Value Health. 2015 Nov;18(7 3,27 1
ONCOLOGIA MEDICA
1 Manso L, Palomo AG, Carrión RP, Cassinello J, Sancho IG, López-Muñiz IC, Olier C, Fernández-Aramburo A, Llorca C, González X, Llorente R, Torregrosa D, Álvarez I, Gálve E, Bueno C, Garau I, García MJ, González-Santiago S, Ballesteros AI, Blanco E, Galán A, González S, Perelló A, Cortés-Funes H, Grávalos C. Anticancer Res. 2015 Dec;35(12):6941-50. PMID: 26637920 Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study. Anticancer Res. 2015 Dec;35(12):6941-50. PMID: 26637920 1,826 4
RADIOTERAPIA
1 Arenas, M; Gascón, M; Rovirosa, A; Hernández, V; Riu, F; López, I; Montero, A; Sabater, S. The effect of lymphadenectomy and radiotherapy on recurrence and survival in endometrial carcinoma. Experience in a population reference centre. Reports of Practical Oncology and Radiotherapy, 2015; 20: 50-6.
UNIDAD DE INVESTIGACIÓN: ANIMALARIO
1 María G Picazo; Dolores C García-Olmo DNA from tissues of young mice is optimal for genotyping Electron J Biotechnol. 18 - 2, pp. 83 - 87. 2015. 0,681 4
UNIDAD DE INVESTIGACIÓN: NEUROPSICOFARMACOLOGÍA
1 SAEZ-ATIENZAR S, MARTÍNEZ-GÓMEZ J, ALONSO-BARBA JI, PUERTA JM, GALINDO MF, JORDÁN J and de la OSSA L. Automatic quantification of the subcellular localization of chimeric GFP protein supported by a two-level Naive Bayes classifier. Expert Systems with Applications.42: 1531-1537. 2015. 2,24 1
2 BONET-PONCE L, SAEZ-ATIENZAR S, da CASA C, FLORES-BELLVER M, BARCIA JM, SANCHO-PELLUZ J, ROMERO FJ, JORDÁN J, GALINDO MF On the mechanism underlying ethanol-induced mitochondrial dynamic disruption and autophagy response. Biochim Biophys Acta. S0925-4439(15)00070-8. doi: 10.1016/j.bbadis.2015.03.006. 2015. 4,882 1
3 Prieto-Martin A, Aroca-Aguilar JD, Sánchez-Sánchez F, Muñoz LJ, López DE, , Escribano J, De Cabo, C Molecular and neurochemical substrates of the audiogenic seizure strains: the GASH:Sal model Epilepsy & Behavior; doi: 10.1016/j.yebeh.2015.05.025. [Epub ahead of print] 2,257 2
4 J Solera, B Rallo, A S Herranz, J M Pardal, R Martin-del Rio, Cde Cabo High glycine levels in the cerebrospinal fluid in Satoyoshi syndrome. Journal of the Neurological Sciences (aceptado) 2,474 2
5 SAEZ-ATIENZAR S, BONET-PONCE L, da CASA C, PEREZ-DOLZ L, BLESA JR, NAVA E, GALINDO MF and JORDAN J Bcl-xL-mediated antioxidant function abrogates the disruption of mitochondrial dynamics induced by LRRK2 inhibition. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. Biochim Biophys Acta, 2015; 1862(1):20-31. 4,882 1
5 BONET-PONCE L, SAEZ-ATIENZAR S, da CASA C, SANCHO-PELLUZ J, BARCIA JM, MARTINEZ-GIL N, NAVA E, JORDÁN J, ROMERO FJ, GALINDO MF. Rotenone Induces the Formation of 4-Hydroxynonenal Aggresomes. Role of ROS-Mediated Tubulin Hyperacetylation and Autophagic Flux Disruption. Mol. Neurobiol., 2015 5,137 1
UNIDAD DE INVESTIGACIÓN: ONCOLOGÍA TRANSLACIONAL
1 Tibau A, Bedard PL, Srikanthan A, Ethier JL, Vera-Badillo FE, Templeton AJ, Ocaña A, Seruga B, Barnadas A, Amir E. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. J Clin Oncol. 2015 Jan 1;33(1):100-6 18,44 1
2 Tibau A, Bedard PL, Srikanthan A, Ethier JL, Vera-Badillo FE, Templeton AJ, Ocaña A, Seruga B, Barnadas A, Amir E. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. J Clin Oncol. 2015 Jan 1;33(1):100-6 18,44 1
3 Ocana A, Seruga B, Amir E. Pathological complete response in breast cancer. Lancet. 2015 Jan 10;385(9963):113. 45,21 1
4 Vera-Badillo FE, Templeton AJ, Duran I, Ocana A, de Gouveia P, Aneja P, Knox JJ, Tannock IF, Escudier B, Amir E. Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis. Eur Urol. 2015 Apr;67(4):740-9 13,93 1
5 Ocana A, Díez-González L, Garcia-Olmo DC, Templeton AJ, Vera-Badillo F, Gascon-Escribano MJ, Serrano-Heras G, Corrales-Sanchez V, Seruga B, Andrés-Pretel F, Pandiella A, Amir E. Circulating DNA and survival in solid tumors. Cancer Epidemiol Biomarkers Prev. 2015 Nov 24 4,125 1
6 AlHashem HY, Al-Mubarak M, Vera-Badillo FE, Templeton AJ, Ocana A, Seruga B, Amir E. Impact of Geographic Region on Benefit of Approved Anticancer Drugs Evaluated in International Phase III Clinical Trials. Clin Oncol (R Coll Radiol). 2015 Nov 2 18,44 1
7 Seruga B, Ocana A, Amir E, Tannock IF. Failures in Phase III: Causes and Consequences. Clin Cancer Res. 2015 Oct 15;21(20):4552-60 8,7 1
8 Ocana A, Ethier JL, Díez-González L, Corrales-Sánchez V, Srikanthan A, Gascón-Escribano MJ, Templeton AJ, Vera-Badillo F, Seruga B, Niraula S, Pandiella A, Amir E. Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: systematic review and meta-analyses. Oncotarget. 2015 Nov 24;6(37):39538-49 6,36 1
9 Pandiella A, Morís F, Ocaña A, Núñez LE, Montero JC. Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2. Oncotarget. 2015 Oct 20;6(32):32856-67 6,36 1
10 Serrano-Heras G, Cuenca-López MD, Montero JC, Corrales-Sanchez V, Morales JC, Núñez LE, Morís F, Pandiella A, Ocaña A. Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors. Oncotarget. 2015 Oct 13;6(31):31272-83. 6,36 1
11 Seoane S, Montero JC, Ocaña A, Pandiella A. Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling node. Oncogene. 2015 Sep 14. doi: 10.1038/onc.2015.337. [Epub ahead of print] 8,459 1
12 Montero JC, García-Alonso S, Ocaña A, Pandiella A. Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling. Oncotarget. 2015 Oct 6;6(30):30057-71 6,36 1
13 Cuenca-López MD, Serrano-Heras G, Montero JC, Corrales-Sánchez V, Gomez-Juarez M, Gascón-Escribano MJ, Morales JC, Voisin V, Núñez LE, Morís F, Bader GD, Pandiella A, Ocaña A. Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer. Oncotarget. 2015 Sep 29;6(29):27923-37. 6,36 1
14 Ocana A, Vera-Badillo F, Templeton A, Tannock I, Amir E. Response. J Natl Cancer Inst. 2015 Aug 17;107(10). 13,58 1
15 Chan M, Chang MC, González R, Lategan B, del Barco E, Vera-Badillo F, Quesada P, Goldstein R, Cruz I, Ocana A, Cruz JJ, Amir E. Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer. PLoS One. 2015 Jul 10;10(7):e0132449. 3,53 1
16 Niraula S, Ocana A, Amir E. One step forward, two steps back: The story of everolimus in advanced breast cancer. Breast. 2015 Oct;24(5):529-31 2,58 3
17 Vera-Badillo FE, Chang MC, Kuruzar G, Ocana A, Templeton AJ, Seruga B, Goldstein R, Bedard PL, Tannock IF, Amir E. Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer. J Clin Pathol. 2015 Oct;68(10):839-43. 7,42 2
18 Srikanthan A, Ethier JL, Ocana A, Seruga B, Krzyzanowska MK, Amir E. Cardiovascular toxicity of multi-tyrosine kinase inhibitors in advanced solid tumors: a population-based observational study. PLoS One. 2015 Mar 27;10(3):e0122735 3,53 1
19 Ocaña A, Diez-Gónzález L, Adrover E, Fernández-Aramburo A, Pandiella A, Amir E. Tumor-infiltrating lymphocytes in breast cancer: ready for prime time? J Clin Oncol. 2015 Apr 10;33(11):1298-9. 18,44 1
20 Templeton AJ, Ace O, Amir E, Vera-Badillo F, Ocana A, Pond GR, Tannock IF. Influence of censoring on conclusions of trials for women with metastatic breast cancer. Eur J Cancer. 2015 Apr;51(6):721-4.  4,82 2
21 Hernández A, Garcia-Delgado P, Garcia-Cardenas V, Ocaña A, Labrador E, Orera ML, Martinez-Martinez F. Characterization of patients' requests and pharmacists' professional practice in oropharyngeal condition in Spain. Int J Clin Pharm. 2015 Apr;37(2):300-9. doi 1,35 3
22 Vera-Badillo FE, Templeton AJ, Duran I, Ocana A, de Gouveia P, Aneja P, Knox JJ, Tannock IF, Escudier B, Amir E. Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis. Eur Urol. 2015 Apr;67(4):740-9.  19,93 1
23 Ocana A, Pandiella A. Novel Synthetic Lethality Approaches for Drug Combinations and Early Drug Development. Curr Cancer Drug Targets. 2015 Dec 3. [Epub ahead of print] 3,52 2
UNIDAD DE INVESTIGACIÓN: UNIDAD DE APOYO A LA INVESTIGACIÓN CLÍNICA
1 Navarro Bravo B, Párraga Martínez I, López-Torres Hidalgo J, Andrés Pretel F, Rabanales Sotos J. Group cognitive-behavioral therapy for insomnia: a meta-analysis. Anales de Psicología, 2015. 31(1):8-18. 0,504 3
2 CÓRCOLES-JIMÉNEZ MP, VILLADA-MUNERA A, Del EGIDO-FERNÁNDEZ MA, CANDEL-PARRA E, MORENO-MORENO M, JIMÉNEZ-SÁNCHEZ MD, PIÑA-MARTÍNEZ A. Recovery of Activities of Daily Living Among Older People One Year After Hip Fracture. Clinical Nursing Research.
DOI: 10.1177/1054773815573261, first published on March 21, 2015.
1,278 2
3 CÓRCOLES-JIMÉNEZ MP, VILLADA-MUNERA A, Del EGIDO-FERNÁNDEZ MA, CANDEL-PARRA E, MORENO-MORENO M, JIMÉNEZ-SÁNCHEZ MD, PIÑA-MARTÍNEZ A. Recovery of Activities of Daily Living Among Older People One Year After Hip Fracture. Clin Nurs Res, December 2015; vol. 24, 6: pp. 604-623., first published on March 21, 2015 1,278 2
UNIDAD DE INVESTIGACIÓN
1 García-Doval I, Pérez-Zafrilla B, Ferrandiz C, Carretero G, Daudén E, de la Cueva P, Gómez-García FJ, Herrera-Ceballos E, Belinchón-Romero I, Sánchez-Carazo JL, López-Estebaranz JL, Alsina M, Ferrán M, Torrado R, Carrascosa JM, Rivera R, Vanaclocha F; BIOBADADERM Study Group. Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort. J Dermatolog Treat. 2015 Sep 25:1-7. 1,669 2
2 Carrascosa JM, Rivera N, Garcia-Doval I, Carretero G, Vanaclocha F, Daudén E, Gómez-García FJ, De-la-Cueva-Dobao P, Herrera-Ceballos E, Belinchón I, Alsina M, Sánchez-Carazo JL, Ferrán M, Lopez-Estebaranz JL, Pérez-Zafrilla B, Llamas M,Rivera R, Ferrándiz C; BIOBADADERM Study Group. Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time. Actas Dermosifiliogr. 2015 Oct;106(8):638-43.
3 Carrascosa JM, Garcia-Doval I, Pérez-Zafrilla B, Carretero G, Vanaclocha F,Daudén E, De la Cueva-Dobao P, Belinchón I, Alsina M, López-Estebaranz JL, Ferrán M, Torrado R, Rivera R, Carazo C, Barboza L, Ferrándiz C; BIOBADADERM Study Group. Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice. J Dermatolog Treat. 2015 Apr 17:1-5. 1,669 2
4 Sanz-Bueno J, Vanaclocha F, García-Doval I, Torrado R, Carretero G, Daudén E, Patricia Ruiz-Genao D, Alsina-Gibert MM, Pérez-Zafrilla B, Pérez-Rial G, Rivera R; members of the BIOBADADERM group. Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database. Actas Dermosifiliogr. 2015 Jul-Aug;106(6):477-82.
5 Carretero G, Ferrandiz C, Dauden E, Vanaclocha Sebastián F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL,Alsina-Gibert M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Carazo C, Rivera R, Jiménez-Puya R, García-Doval I; BIOBADADERM Study Group. Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry. J Eur Acad Dermatol Venereol. 2015 Jan;29(1):156-63. 2,826 1
UROLOGÍA
1 Fernández Anguita PJ, Giménez Bachs JM, Martínez Sanchíz C, Perán Teruel M, Núñez Sarrión MÁ, Pastor Navarro H, Martínez Ruíz J, García R, Virseda Rodríguez JA. Metástasis cutánea de un carcinoma urotelial de vejiga. Un caso Arch Esp Urol. 2015 Oct;68(8):681-2. 0,309 4
2 Pastor-Navarro H, Carrión-López P, Martínez-Ruiz J, Pastor-Guzmán J, Martínez-Verduch M, García-Ibarra F, Virseda-Rodríguez JA. Extrofia vesical y vejiga rectal Arch Esp Urol. 2015 Jun;68(5):509. 0,309 4
3 Virseda Rodríguez JA. Dr. José Ollé Carreras (1933-2015), en el recuerdo. Arch Esp Urol. 2015 Mar;68(2):194. 0,309 4
4 VIrseda Rodríguez JA. El Segundo riñon trasplantado en España Arch Esp Urol 2015 May;68(4):401-12 0,309 4

 

2014
Publicaciones por departamento 2014
Autores Artículo Revista FI* Cuartil
Análisis Clínicos
1 Alcaraz AJ, Gil-Ruiz MA, Castillo A, López J, Romero C, Fernández SN, Carrillo A. Postoperative neutrophil gelatinase-associated lipocalin predicts acute kidney injury after pediatric cardiac surgery. Pediatric Critical Care Medicine.2014;15(2):121-30. 0,891 1
Atención Primaria
1 López-Torres Hidalgo J, Andrés Pretel F, Navarro Bravo B, Escobar Rabadán F, Serrano Selva JP, Latorre Postigo JM, Párraga Martínez I. Training medical students about the hazardous drinking using simple assessment techniques. Health Education Journal. 2014; 73(3):295-302. doi:10.1177/0017896912471050. 1,39 2
2 Párraga I, López-Torres J, Del-Campo JM, Villena A, Morena S, Escobar F en representación del Grupo ADSCAMFYC. Seguimiento de la adherencia al tratamiento antidepresivo en pacientes que inician su consumo. Aten Primaria. 2014; 46(7):357-366. 0,957 3
3 Ballester Vidal MR, de la Rosa Alarcón L, Mansilla Ortuño MJ, Tello Nieves G, de la Ossa Moreno M, Párraga Martínez I. Cumplimiento del tratamiento antibiótico en niños en atención primaria. Rev Clin Med Fam. 2014; 7(1):32-38.
4 Del Pozo K, López-Torres J, Simarro MJ, Navarro B, Olcina J, Gil V. Study of the factors influencing the preparation of advance directives, factors influencing the preparation of advance directives. Archives of Gerontology and Geriatrics. 2014; 58:20-24. 1,858 3
5 López-Torres J, en representación del Grupo ANVITAD. Efecto del calcio y la vitamina D en la reducción de caídas de las personas mayores: ensayo clínico aleatorizado frente a placebo. Medicina Clínica (Barc). 2014; 142(3):95–102. 1,417 3
6 Martín Lesende I, López-Torres Hidalgo J, Gorroñogoitia Iturbe A, de-Hoyos Alonso MC, Baena Díez JM, Herreros Herreros Y. Actividades preventivas en los mayores. Atención Primaria. 2014; 46(Supl 4):75-81. 0,957 3
7 López-Torres Hidalgo J, Basora Gallisà J, Orozco Beltrán D, Bellón Saameño JA. Mapa bibliométrico de la investigación realizada en atención primaria en España durante el periodo 2008-2012. Atención Primaria. 2014; 46(10):541-8. 0,957 3
8 Ayuso-Raya MC, Escobar-Rabadán F, López-Torres Hidalgo J, Montoya-Fernández J, Téllez-Lapeira JM, Bonal-Pitz PP. Validez de predicción de un cuestionario de conocimientos y actitudes hacia la medicina familiar. Atención Familiar. 2014; 21(1):7-11.
9 López-Torres Hidalgo J, Boix Gras C, Téllez Lapeira JM, Martín Oliver J, López-Torres López J. Contribución de los médicos de familia a la elaboración de guías de práctica clínica. Revista de Calidad Asistencial. 2014; 29:117-9.
10 Del Pozo K, López-Torres J, Simarro MJ, Navarro B, Rabanales J, Gil V. Características sociosanitarias de quienes formalizan el documento de voluntades anticipadas. Semergen. 2014; 40(3):128-133.
Cirugía Torácica
1 Antonio Francisco Honguero Martínez, Antonio Arnau Obrer, Santiago Figueroa Almánzar, Pablo León Atance and Ricardo Guijarro Jorge. Analysis of expression of vascular endothelial growth factor A and hypoxia inducible factor-1alpha in patients operated on stage I non-small cell lung Cancer Lung Cancer International. Volume 2014 (2014)
2 Carlos A. Rombolá, Marta Genovés Crespo, Pedro J. Tárraga López, María Dolores García Jiménez, Antonio F. Honguero Martínez, Pablo León Atance, Claudia R. Rodríguez Ortega, Ana Triviño Ramírez y José Antonio Rodríguez Montes. Tratamiento de la eventración diafragmática en adultos mediante plicatura diafragmática asistida por videotoracoscopia. ¿Es una técnica difundida en nuestro medio? Revisión de la literatura y resultados de una encuesta NacionaL Cir Esp. 2014; 92(7): 453-462. 0,743 4
3 Ober van Gómez López, Ana María García Vicente, Antonio Francisco Honguero Martínez, Ángel María Soriano Castrejón, Germán Andrés Jiménez Londoño, José Manuel Udias and Pablo León Atance. Heterogeneity in [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Non–Small Cell Lung Carcinoma and Its Relationship to Metabolic Parameters and Pathologic Staging Mol Imaging. 2014; 13(nov): 1-12. 1,962 2
Endocrinología y Nutrición
1 C. Lamas, C. del Pozo y C. Villabona, en representación del Grupo de Neuroendocrinología de la SEEN Guía clínica de manejo de la diabetes insípida y del síndrome de secreción inapropiada de hormona antidiurética en el postoperatorio de la cirugía hipo?saria Endocrinología y Nutrición 2014; 61(4): e15-e24.
Farmacia
1 Domingo-Chiva E, Ruiz-Ramos J, Marqués-Miñana MR, Vallado-lid-Walsh A, Poveda-Andres JL “Drug interaction between oral cyclosporine modified and iron” Annals of Pharmacotherapy, 2014; 48(7):932-5 2,059 3
2 Domingo Chiva E, De Mora Alfaro MJ, Pascual Martínez M, Garrigues Sebastiá MR, García Gómez C, García Martínez EM.   Efectividad del tratamiento antiemético como terapia de soporte en pacientes con cáncer de mama en tratamiento quimioterápico Revista de la O.F.I.L., 2014; 24;4:222-233
3 J. Ruiz Ramos, E. Domingo Chiva, C. Planells Herrero y J. L. Poveda Andrés. Síndrome hemofagocítico secundario a la administración de peg-interferon Farmacia Hospitalaria, 2014; 38(1):69-78  
4 T Requena, A Ais, M Yébenes, M A Casado, M Rueda, EUPTHEA-Persistence Research Group (addendum (S Plata Paniagua) Persistence with oral antiviral therapy in previously untreated patients with chronic hepatitis B in Spain: the EUPTHEA study. European Journal of Hospital Pharmacy, 2014; 0:1-6 0,433 4
5 Palmou-Fontana N. · Sánchez Gaviño J.A. · McGonagle D. · García-Martinez E. Iñiguez de Onzoño Martín L Tocilizumab-Induced Psoriasiform Rash in Rheumatoid Arthritis Dermatology, 2014; 228:311-313 1,569 2
6 B. Bonaga Serrano, R. Aldaz Francés, M. R. Garrigues Sebastiá, M. Hernández San Salvador  Uso de las herramientas de la Web 2.0 por parte de los farmacéuticos hospitalarios Farmacia Hospitalaria, 2014; 38(2):100-104
GERIATRÍA
1 Alfonso Silguero SA, Martínez-Reig M, Gómez Arnedo L, Juncos Martínez G, Romero Rizos L, Abizanda Soler P. Chronic disease, mortality and disability in an elderly Spanish population: The FRADEA study. Rev Esp Geriatr Gerontol 2014; 49: 51-8.
2 Martínez-Reig M, Gómez-Arnedo L, Alfonso-Silguero SA, Juncos-Martínez G, Romero L, Abizanda P. Nutritional risk, nutritional status and incident disability in older adults. The FRADEA Study. J Nutr Health Aging 2014; 18: 270-6. 2,996 2
3 Abizanda Soler P. Frailty: The new paradigm of health care in the elderly. Med Clin (Barc) 2014; 143: 205-6. 1,417 3
4 González-Vaca J, de la Rica-Escuín M, Silva-Iglesias M, Arjonilla-García MD, Varela-Pérez R, Oliver-Carbonell JL, Abizanda P. Frailty in INstitutionalized older adults from ALbacete. The FINAL Study: Rationale, design, methodology, prevalence and attributes. Maturitas 2014; 77: 78-84. 2,942 1
5 Caballero Beatriz, Rubio-González Adrián, Ochoa Yaiza, Martínez-Reig Marta, Sánchez-Jurado Pedro Manuel, Romero Luis, Solano Juan José, Abizanda Pedro, Coto-Montes Ana. Associations of the antioxidant capacity and hemoglobin levels with functional physical performance of the upper and lower body limbs, respectively: Impact on pre-frailty. Age (Dordr) 2014. 36: 851-67. 3,39 1
6 Abizanda P, Romero L, Sánchez-Jurado PM, Martínez-Reig M, Alfonso-Silguero SA, Rodríguez-Mañas L. Age, frailty, disability, institutionalization, multimorbidity or comorbidity. Which are the main targets in older adults? J Nutr Health Aging 2014; 18: 622-7. 2,996 2
7 de la Rica-Escuín M, González-Vaca J, Varela-Pérez R, Arjonilla-García MD, Silva-Iglesias M, Oliver-Carbonell JL, Abizanda P. Frailty and mortality or incident disability in institutionalized older adults: The FINAL Study. Maturitas 2014; 78: 329-34. 2,942 1
8 Flores Ruano T, Cruz Jentoft AJ, González Montalvo JI, López Soto A, Abizanda Soler P. Geriatric assessment tools in Spanish Geriatric Departments. Rev Esp Geriatr Gerontol 2014; 49: 235-42.
9 Blanco-Reina E, Ariza-Zafra G, Ocaña-Riola R, León-Ortiz M. 2012 American Geriatrics Society Beers criteria: enhanced applicability for detecting potentially inappropriate medications in European older adults? A comparison with the Screening Tool of Older Person's Potentially Inappropriate Prescriptions. J Am Geriatr Soc 2014; 62: 1217-23. 4,572 1
NEUMOLOGÍA
1 Julio Sanchez de Cos y Grupo Cooperativo GCCB-II SEPAR(Ana Núñez et al). Tumor, Node and Metastasis Classification of Lung Cancer. M1a versus M1b. Analysis of M Descriptors and other Prognostic Factors Lung cancer 2014; 84: 182-189. 3,958 1
2 Rodríguez González-Moro JM, Callejas González FJ et al. EPOC: consenso de expertos EXPERT 10. Progresión enfermedad / estadios tempranos / mortalidad Monogr. Arch. Bronconeumol. 2014; 1 (1): 61-74. 1,823 3
3 Callejas González FJ, Genovés Crespo M, Cruz Ruiz J and Tárraga López PJ Relevance of Anxiety and Depression in Chronic Obstructive Pulmonary Disease (COPD) Current Respiratory Medicine Reviews 2014, Vol 10, Issue 4. Pages 221-229
NEUROLOGÍA
1 Jimenez-Caballero PE, Coloma-Navarro R, Segura Martin T, Ayo Martin O. Cerebral hemodynamic changes at basilar artery in patients with obstructive sleep apnea syndrome. A case-control study. Acta Neurol Scand 2014 Feb;129(2):80-4. 2,43 2
2 Garcia-Garcia J, Fernandez-Diaz E, Palazon-Garcia E, Ayo-Martin O, Segura T. Occipital neuralgia secondary to vasculitis of the occipital artery. Diagnosis using colour dúplex. Rev Neurol 2014; 58:430-2 0,83 4
3 Ayo-Martín O, García-García J, García-Muñozguren S, Segura T. Effectiveness of transcranial ultrasound in deep brain stimulation. Rev Neurol 2014; 59:175. 0,83 4
4 Pardal-Fernández JM, Arciniegas A, Perona-Moratalla AB, Garcia-Garcia J. Contribution made by sonography in a patient with motor neuropathy with conduction blocks Rev Neurol 2014; 16;58: 184. 0,83 4
5 María Monteagudo, Elena Palazón-García, Elena Lozano Setién, Jorge García García. Signo del cornete negro en un caso de mucormicosis rinocerebral. Rev Neurol 2014; Rev Neurol 2014 ;58:234-5. 0,83 4
6 Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Martí-Fábregas J, Gállego J, Krupinski J, Gomis M, Cánovas D, Carné X, Deulofeu R, Román LS, Oleaga L, Torres F, Planas AM; URICO-ICTUS Investigators. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. Lancet Neurol. 2014;13:453-60. 21,896 1
7 Vivancos J, Gilo F, Frutos R, Maestre J, García-Pastor A, Quintana F, Roda JM, Ximénez-Carrillo A; por el Comitéad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN:, Díez Tejedor E, Fuentes B, Alonso de Leciñana M, Alvarez-Sabin J, Arenillas J, Calleja S, Casado I, Castellanos M, Castillo J, Dávalos A, Díaz-Otero F, Egido JA, Fernández JC, Freijo M, Gállego J, Gil-Núñez A, Irimia P, Lago A, Masjuan J, Martí-Fábregas J, Martínez-Sánchez P, Martínez-Vila E, Molina C, Morales A, Nombela F, Purroy F, Ribó M, Rodríguez-Yañez M, Roquer J, Rubio F, Segura T, Serena J, Simal P, Tejada J. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment. Neurologia 2014; 29:353-70. 1,32 4
8 Hacke W, Schellinger PD, Albers GW, Bornstein NM, Dahlof BL, Fulton R, Kasner SE, Shuaib A, Richieri SP, Dilly SG, Zivin J, Lees KR; NEST 3 Committees and Investigators. Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial. Stroke 2014;45:3187-93. 5,761 1
9 López Fernández JC, Masjuan Vallejo J, Arenillas Lara J, Blanco González M, Botia Paniagua E, Casado Naranjo I, Deyá Arbona E, Escribano Soriano B, Freijo Guerrero MM, Fuentes B, Gállego Cullere J, Geffners Sclarskyi D, Gil Núñez A, Gómez Escalonilla C, Lago Martin A, Legarda Ramírez I, Maciñeiras Montero JL, Maestre Moreno J, Moniche Álvarez F, Muñoz Arrondo R, Purroy García F, Ramírez Moreno JM, Rebollo Álvarez Amandix M, Roquer J, Rubio Borrego F, Segura T, Serrano Ponza M, Tejada García J, Tejero Juste C, Vidal Sánchez JAVega G. Analysis of stroke care resources in Spain in 2012: Have we benefitted from the Spanish Health System's stroke care strategy? Neurologia 2014 29:387-96. 1,32 4
10 Alonso de Leciñana M, Egido JA, Casado I, Ribó M, Dávalos A, Masjuan J, Caniego JL, Martínez Vila E, Díez Tejedor E; ad hoc committee of the SEN Study Group for Cerebrovascular Diseases, Fuentes B, Álvarez-Sabin J, Arenillas J, Calleja S, Castellanos M, Castillo J, Díaz-Otero F, López-Fernández JC, Freijo M, Gállego J, García-Pastor A, Gil-Núñez A, Gilo F, Irimia P, Lago A, Maestre J, Martí-Fábregas J, Martínez-Sánchez P, Molina C, Morales A, Nombela F, Purroy F, Rodríguez-Yañez M, Roquer J, Rubio F, Segura T, Serena J, Simal P, Tejada J, Vivancos J. Guidelines for the treatment of acute ischaemic stroke. Neurologia. 2014; 29: 102-22 1,32 4
11 Fuentes B, Gállego J, Gil-Nuñez A, Morales A, Purroy F, Roquer J, Segura T, Tejada J, Lago A, Díez-Tejedor E; por el Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN:, Alonso de Leciñana M, Alvarez-Sabin J, Arenillas J, Calleja S, Casado I, Castellanos M, Castillo J, Dávalos A, Díaz-Otero F, Egido JA, López-Fernández JC, Freijo M, García Pastor A, Gilo F, Irimia P, Maestre J, Masjuan J, Martí-Fábregas J, Martínez-Sánchez P, Martínez-Vila E, Molina C, Nombela F, Ribó M, Rodríguez-Yañez M, Rubio F, Serena J, Simal P, Vivancos J. Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type. Neurologia. 2014; 29:168-183. 1,32 4
12 Purroy F, Jiménez Caballero PE, Gorospe A, Torres MJ, Alvarez-Sabin J, Martínez-Sánchez P, Cánovas D, Freijo M, Egido JA, Ramírez-Moreno JM, Alonso-Arias A, Rodríguez-Campello A, Casado-Naranjo I, Martí-Fàbregas J, Silva Y, Cardona P, Morales A, García-Pastor A, Arenillas JF, Segura T, Jiménez C, Masjuán J. How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up. J Neurol 2014; 261:1614-21 3,377 2
13 Parrilla G, Carreón E, Zamarro J, Espinosa de Rueda M, García-Villalba B, Marín F, Hernández-Fernández F, Morales A, Fernández-Vivas M, Núñez R, Moreno A. Recanalization and Mortality Rates of Thrombectomy With Stent-Retrievers in Octogenarian Patients with Acute Ischemic Stroke. Cardiovasc Intervent Radiol 2014 Jun 13. 2,07 2
14 Pardal-Fernández JM, Palazón-García E, Hernández-Fernández F, de Cabo C. Contribution of a new electrophysiologic test to Morton's neuroma diagnosis. Foot Ankle Surg 2014;20:109-14. 1,6 2
15 Hernández-Fernández F, Parrilla G, García-Villalba B, Espinosa de Rueda M, Zamarro J, Moreno A. Comparison between proximal versus distal protrection devices in 287 cases of carotid revascularization using angioplasty and stenting: periprocedure complications, morbidity and mortality. Cardiovasc Intervent Radiol 2014;37:639-45 2,07 2
16 Moreno A, Hernández-Fernández F. IMS III, SYNTHESIS and MR-RESCUE studies: the end of endovascular treatment for stroke? Radiologia 2014;56:2-6.
17 Hacke W1, Schellinger PD2, Albers GW2, Bornstein NM2, Dahlof BL2, Fulton R2, Kasner SE2, Shuaib A2, Richieri SP2, Dilly SG2, Zivin J2, Lees KR2; NEST 3 Committees and Investigators.

Collaborators (61)
Hacke W, Zivin JA, Schellinger PD, Albers GW, Bornstein NM, Dahlof BL, Fulton R, Kasner SE, Shuaib A, Broderick J, Ivanova A, Johnston K, Lees KR, Norrving B, Albers G, Alexandrov A, Brown D, Capone P, Chiu D, Clark W, Cochran J, Deredyn C, Devlin T, Hickling W, Howell G, Huang D, Hussain S, Mallenbaum S, Moonis M, Nash M, Rymer M, Taylor R, Tremwel M, Buck B, Shuaib A, Perez J, Gerloff C, Greiwing B, Grond M, Hamman G, Haarmeiter T, Jander S, Kohrmann M, Ritter M, Schellinger P, Schneider D, Sobesky J, Steiner T, Steinmetz H, Veltkamp R, Weimar C, Gruber F, Andersson B, Welin L, Leys D, Tatlisumak T, Luft A, Lyrer P, Michel P, Molina C, Segura T.
Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial Stroke. 2014 Nov;45(11):3187-93 5,761 1
OFTALMOLOGÍA
1 Copete S, Flores-Moreno I, Montero J, Duker JS, Ruiz-Moreno JM. Direct Comparison of Spectral-Domain and Swept-Source OCT in the Measurement of Choroidal Thickness in Normal Eyes Br J Ophthalmol 2014;98:334-338 2,976 1
2 Jose Maria Caire, Sergio Recalde, Alvaro Velazquez, Laura Garcia-Garcia, Nicholas Reiter, Jaouad Anter, Patricia Fernandez-Robredo, Alfredo Garcia-Layana MD. On behalf of the Spanish Multi-center Group on AMD* Growth of Geographic Atrophy on Fundus Autofluorescence and Polymorphisms of CFH, CFB, C3, FHR1–3, and ARMS2 in Age-Related Macular Degeneration JAMA Ophthalmology 2014;132:528-534. 3,318 1
3 Montero JA, Yanez-Castro G, Sanchis-Merino ME, Ruiz-Moreno JM. Bevacizumab in vitreous haemorrhage secondary to radiation retinopathy BMJ Case Rep. 2014 Feb 7;2014.
4 Jorge Ruiz-Medrano, Ignacio Flores-Moreno, Pablo Peña-García, Javier A Montero, Jay S Duker, José M Ruiz-Moreno. Macular choroidal thickness profile in a healthy population measured by Swept-Source Optical Coherence Tomography Invest Ophthalmol Vis Sci 2014;55:3532-42 3,404 1
5 Boyer DS, Goldbaum M, Leys AM, Starita C; for the V.I.S.I.O.N. Study Group. Collaborators:…, Ruiz Moreno J, … Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study Br J Ophthalmol 2014;98:1543-6. 2,976 1
6 A García-Layana, L Arias, M S. Figueroa, J Araiz, J M Ruiz-Moreno, J García-Arumí, F Gómez-Ulla, M I López-Gálvez, F Cabrera-López, JM García-Campos, J Monés, E Cervera, F Armadá, and R Gallego-Pinazo, A Piñero Bustamante, MA Serrano-García. A delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration Journal of Ophthalmology 2014; ID 595132. 1,425 3
7 J Cunha-Vaz, P Ashton, R Iezzi, P Campochiaro, PU. Dugel, FG. Holz, M Weber, RP. Danis, BD. Kuppermann, C Bailey, K Billman, B Kapik, F Kane, K Green, for the FAME Study Group* Sustained Delivery Fluocinolone Acetonide Vitreous Implants. Long-Term Benefit in Patients with Chronic Diabetic Macular Edema Ophtahlmology 2014;121:1892-1903. 6,135 1
8 A García-Layana, M S. Figueroa, L Arias, J Araiz, J M Ruiz-Moreno, J García-Arumí, F Gómez-Ulla, M I López-Gálvez, F Cabrera-López, JM García-Campos, J Monés, E Cervera, F Armadá, and R Gallego-Pinazo. Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration The ScientificWorld Journal 2014
9 Collateral vessels after retinal vein occlusion treated with intravitreal bevacizumab Austin J Clin Ophthalmol 2014
10 Flores-Moreno I, Ruiz-Medrano J, Duker JS, Ruiz-Moreno JM. The relationship between retinal and choroidal thickness and visual acuity in highly myopic eyes. Br J Ophthalmol., 2014; 98(1): 143.4 2,976 1
11 Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H, Hashad Y, Whitcup SM; Ozurdex MEAD Study Group. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology, 2014; 121:1904-14 6,135 1
12 Ruiz-Medrano J, Flores-Moreno I, Peña-García P, Montero JA, Duker JS,
Ruiz-Moreno JM.
Author response: Choroidal thickness and axial length. Invest. Ophthalmol Vis Sci. 2014 Aug 14;55(8 3,404 1
ONCOLOGIA MEDICA
1 J. Aparicio, P. Maroto, X. García del Muro, A. Sánchez-Muñoz, J. Gumà, M. Margelí,A. Sáenz, N. Sagastibelza, D. Castellano, J. A. Arranz, D. Hervás, R. Bastús, A. Fernández-Aramburo, J. Sastre, J. Terrasa, M. López-Brea, J. Dorca, D. Almenar, J. Carles, A. Hernández & J. R. Germà Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive,risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG). Annals of Oncology,2014; 25: 2173–2178 7,04 1
2 Peiró G, Ortiz-Martínez F, Gallardo A, Pérez-Balaguer A, Sánchez-Payá J, Ponce JJ, Tibau A, López-Vilaro L, Escuin D, Adrover E, Barnadas A, Lerma E Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. Br J Cancer, 2014; 111:689-95 4,836 1
3 Balañá C, Vaz MA, Lopez D, de la Peñas R, García-Bueno JM, Molina-Garrido MJ, Sepúlveda JM, Cano JM, Bugés C, Sanz SM, Arranz JL, Perez-Segura P, Rodriguez A, Martin JM, Benavides M, Gil M. Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain. Clin Transl Oncol, 2014; 16:273-9 2,077 3
4 Ortiz-Martínez F, Perez-Balaguer A, Ciprián D, Andrés L, Ponce J, Adrover E, Sánchez-Payá J, Aranda FI, Lerma E, Peiró G. Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence. Hum Pathol, 2014; 45:504-12 2,769 2
RADIODIAGNÓSTICO
1 Pastor Juan, MR. Dolor epigástrico y en hipocondrio derecho; más allá del cólico biliar. Radiología Abdominal: revista oficial de la SEDIA. Vol. 14, Nº. 1, 2014, pág. 8.
RADIOTERAPIA
1 Sabater, S; Sevillano, MM; Andrés, I; Berenguer, R; Machin-Hamalainen, S; Arenas, M. Dose accumulation, during vaginal cuff brachytherapy based on rigid/deformable registration versus single plan addition.   Brachytherapy, 2014; 13(4): 343-51. 2,758 2
2 Arenas M, Hernández V, Farrús B, Müller K, Gascón M, Pardo A, Berenguer R, Sabater, S. Do breast cups improve breast cancer dosimetry? A comparative study for patients with large or pendulous breasts. Acta Oncologica, 2014; 53: 795-801. 2,997 2
3 Sabater, S; Berenguer, R; Honrubia-Gomez, P; Rivera, M; Nuñez, A; Jimenez-Jimenez, E; Martos, A; Ramirez-Castillejo, C How air influences radiation dose deposition in multiwell culture plates: a Monte Carlo simulation of radiation geometry. Journal of Radiation Research, 2014; 55: 1009-14. 1,797 2
4 Sabater, S; Arenas, M; Berenguer, R; Jimenez-Jimenez, E. In regard to Boyle et al. Brachytherapy, 2014; 13(5): 525. 2,758 2
5 Jimenez-Jimenez, E; Sabater, S; Villas, MV. Tension pneumocephalus related to radiotherapy for nasopharyngeal carcinoma. Case Reports in Oncological Medicine, 2014
6 Arenas, M; Sabater, S; Gascón, M; Henríquez, I; Bueno, MJ; Rius, A; Rovirosa, A; Gómez, D; Lafuerza, A; Biete, A; Colomer, J. Quality assurance in radiotherapy: analysis of the causes of not starting or early radiotherapy withdrawal. Radiation Oncology. 2014; 9:260 2,546 2
UNIDAD DE INVESTIGACIÓN: ANIMALARIO
1 Elena Caminos; Cecilia F Vaquero; Dolores C García Olmo Green mice' display limitations in enhanced green fluorescent protein expression in retina and optic nerve cells. Histol Histopathol. 29 - 12, pp. 1601 - 1612. 2014. 2,096 2
2 Marta Giral; Dolores C García Olmo; Mónica Gómez-Juárez; Ignacio A Gómez de Segura. Anaesthetic effects in the ferret of alfaxalone alone and in combination with medetomidine or tramadol: a pilot study. Lab Anim. 48 - 4, pp. 313 - 320. 2014. 1,2 2
UNIDAD DE INVESTIGACIÓN: NEUROPSICOFARMACOLOGÍA
1 Pardal-Fernández JM, Palazón-García E, Hernández-Fernández F, de Cabo C. Contribution of a new electrophysiologic test to Morton’s neuroma diagnosis. Foot and Ankle Surgery 20(2) 109-114, 2014. 0,845 3
2 SÁEZ-ATIENZAR S, BONET-PONCE L, BLESA J, MURPHY M, JORDAN J and GALINDO MF. The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derivate ROS signaling. Cell Death & Disease.
5: e1328. doi: 10.1038/cddis.2014.320.
2014.
5,014 2
3 FLORES-BELLVER M, BONET-PONCE L, BARCIA JM, GARCIA-VERDUGO JM, MARTINEZ-GIL N, SAEZ-ATIENZAR S, SANCHO-PELLUZ J, JORDÁN J, GALINDO MF, ROMERO FJ. Autophagy and mitochondrial alterations in human retinal pigment epithelial cells induced by ethanol. Implications of 4-hydroxy-nonenal. Cell Death and Disease. 5: e1328. doi: 10.1038/cddis.2014.288. 2014. 5,014 2
4 GALINDO MF. Biotecnología Farmacéutica: Anticuerpos monoclonales. Aula de Farmacia, 2014; 10(102):35-42.
UNIDAD DE INVESTIGACIÓN: ONCOLOGÍA TRANSLACIONAL
1 Montero JC, Esparís-Ogando A, Re-Louhau MF, Seoane S, Abad M, Calero R, Ocaña A, Pandiella A. Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer. Oncogene. 2014 Jan 9;33(2):148-56 8,459 1
2 Vera-Badillo FE, Templeton AJ, de Gouveia P, Diaz-Padilla I, Bedard PL, Al-Mubarak M, Seruga B, Tannock IF, Ocana A, Amir E. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2014 Jan;106(1):djt319 12,583 1
3 Al-Mubarak M, Tibau A, Templeton AJ, Cescon DW, Ocana A, Seruga B, Amir E. Extended adjuvant tamoxifen for early breast cancer: a meta-analysis. PLoS One. 2014 Feb 20;9(2):e88238. 3,53 1
4 Ocaña A, Freedman O, Amir E, Seruga B, Pandiella A. Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors. Cancer Metastasis Rev. 2014 Mar;33(1):295-307 7,23 1
4 Ocana A, Vera-Badillo F, Al-Mubarak M, Templeton AJ, Corrales-Sanchez V, Diez-Gonzalez L, Cuenca-Lopez MD, Seruga B, Pandiella A, Amir E. Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis. PLoS One. 2014 Apr 28;9(4):e95219. 3,53 1
5 Cuenca-López MD, Montero JC, Morales JC, Prat A, Pandiella A, Ocana A. Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling. BMC Cancer. 2014 Apr 30;14:302. 3,36 2
6 Seruga B, Zadnik V, Kuhar CG, Marinko T, Cufer T, Zakotnik B, Zorman D, Ocana A, Amir E. Association of aromatase inhibitors with coronary heart disease in women with early breast cancer. Cancer Invest. 2014 May;32(4):99-104. 2,21 3
7 Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, Tannock IF, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014 May 29;106(6):dju124. 13,58 1
8 Vera-Badillo FE, Napoleone M, Ocana A, Templeton AJ, Seruga B, Al-Mubarak M, AlHashem H, Tannock IF, Amir E. Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2014 Jul;146(2):235-44 3,94 1
9 Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T, Seruga B, Ocaña A, Tannock IF, Amir E. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1204-12. 4,125 1
10 Vera-Badillo FE, Ocana A, Templeton AJ, Tibau A, Amir E, Tannock IF. Raising concern about the American Society of Clinical Oncology conflict of interest policy amendment. J Clin Oncol. 2014 Oct 1;32(28):3197. 18,44 1
11 Templeton AJ, Diez-Gonzalez L, Ace O, Vera-Badillo F, Seruga B, Jordán J, Amir E, Pandiella A, Ocaña A. Prognostic relevance of receptor tyrosine kinase expression in breast cancer: a meta-analysis. Cancer Treat Rev. 2014 Oct;40(9):1048-55 7,58 1
12 Niraula S, Amir E, Vera-Badillo F, Seruga B, Ocana A, Tannock IF. Risk of incremental toxicities and associated costs of new anticancer drugs: a meta-analysis. J Clin Oncol. 2014 Nov 10;32(32):3634-42. 18,44 1
13 Ortiz-Ruiz MJ, Álvarez-Fernández S, Parrott T, Zaknoen S, Burrows FJ, Ocaña A, Pandiella A, Esparís-Ogando A. Therapeutic potential of ERK5 targeting in triple negative breast cancer. Oncotarget. 2014 Nov 30;5(22):11308-18. 6,36 1
14 Ocaña A, Montero JC, Pandiella A. Achilles' heel of triple negative cancer. Oncoscience. 2014 Dec 13;1(12):763-4 6,36
15 Brana I, Ocana A, Chen EX, Razak AR, Haines C, Lee C, Douglas S, Wang L, Siu LL, Tannock IF, Bedard PL. A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin. Invest New Drugs. 2014 Dec;32(6):1269-77 2,92 2
UNIDAD DE INVESTIGACIÓN: UNIDAD DE APOYO A LA INVESTIGACIÓN CLÍNICA
1 Cabello R, Navarro B, Latorre JM y Fernández-Berrocal P. Ability of university-level education to prevent age-related decline in emotional intelligence. Frontiers in aging and neuroscience, 2014. 6. Article 37. 4 1
2 Navarro Bravo B, López-Torres Hidalgo J, Andrés Pretel F, Párraga Martínez I, Fernández de Peñaranda A, Gómez JD, Armero C. Advances directives from the point of view of the primary care physicians in Spain. Population Health Management. Population Health Management. 2014; 17(3): 197-8. 1,509 3
3 Córcoles-Jiménez MP Integrando la evidencia en la práctica clínica. El complejo Hospitalario Universitario de Albacete como centro comprometido con la excelencia en cuidados. Nure Investigación. 2014; 72.
UNIDAD DE INVESTIGACIÓN
1 García-de Marcos JA; Pérez-Zafrilla B; Arriaga A; Arroyo-Rodríguez S; Poblet. Human papillomavirus in carcinomas of the tongue: clinical and prognostic. Int J Oral Maxillofac Surg. 2014 Mar 43(3):274 - 280. 1,565 2
UROLOGÍA
1 PASTOR NAVARRO H, CARRIÓN LOPEZ P, MARTINEZ RUIZ J, PASTOR GUZMÁN JM, SALINAS SÁNCHEZ AS, VIRSEDA RODRÍGUEZ JA Duplicidad uretral colateral en un adulto Arch. Esp. Urol. 2014; 67 (4): 345-349 0,309 4
2 Pastor Navarro H, Martinez Sanchiz C, Peran Teruel M, Nam Cha SH, Pastor Guzman JM, Martinez Corcoles B, Virseda Rodriguez JA. Nefroma quístico multilocular: presentación de un caso clínico Arch Esp Urol. 2014; 67(4):337-41. 0,309 4
3 Virseda Rodriguez JA, Martinez-Ruiz J, Carrion-Conde P, Peran-Teruel M, Fernandez Anguita PJ. Acceso supramesocólico al pedículo renal izquierdo: descripción anatomica y quirúrgica Arch Esp Urol. 2014;67(3):231-6. 0,309 4

 

2013
Publicaciones por departamento 2013
Autores Artículo Revista FI* Cuartil
Anatomía Patológica
1 Nam-Cha SH, Serrano-Vargas R, Escario E, Azaña JM, Calero-Oliver R, Martín AG, Poblet E. CD133 Expression in Normal Skin and in Epithelial Cutaneous Tumors. Biomed Res Int. 2013 2.880  
Anestesia y REA
1 Rodríguez-Rubio L, Martínez-Lucas PL, Jiménez-Tortosa R, Monsalve-Naharro JA. Rett syndrome: Anaesthetic considerations and pain threshold assessment in scoliosis surgery. Rev Esp Anestesiol Reanim. 2013 Jan 16.    
2 Monsalve Naharro JA, de Capadocia Rosell J, García Jiménez MD, Jiménez Vizuete JM. Postoperative hepatic herniation. Rev Esp Anestesiol Reanim. 2013 Aug-Sep;60(7):417.    
3 Gerónimo-Pardo M. Doses of anti-infectives for systemic use are scarcely notified in clinical cases reported to the Revista Española de Anestesiología y Reanimación. Rev Esp Anestesiol Reanim. 2013 Jun 27.    
4 Ayelo Navarro A, Gerónimo Pardo M, Torres Lamberti V, Mateo Cerdán CM, Jiménez Vizuete JM, Peyro García R. Salmonella enteritidis bacteraemia as clinical onset of acquired immune deficiency syndrome. Rev Esp Anestesiol Reanim. 2013 Feb;60(2):103-5.    
5 Martínez-Blázquez A, de Capadocia-Rosell J, Cuesta-Montero P, Marín-Sánchez A. Reply to the article "Hemolysis, elevated liver enzymes and low platelet count in pregnancy: Differential diagnosis" Rev Esp Anestesiol Reanim. 2013 Nov 4.    
Atención Primaria
1 Navarro B, López-Torres J, Andrés-Pretel F, Latorre JM, Montes MJ y Párraga I. Validation of the Insomnia in the Elderly Scale (IES) for the detection of insomnia in older adults. Geriatrics and Gerontology International, 2013. 13(3): 646-653. 2.167 Q3
2 López-Torres J, Párraga I, Del Campo JM, Villena A y ADSCAMFYC Group. Follow up of patients who start treatment with antidepressants: treatment satisfaction, treatment compliance, efficacy and safety. BMC Psychiatry, 2013. 13:65. 2.233 Q2
3 López-Torres Hidalgo J, Navarro Bravo B, Párraga Martinez I, Andrés Pretel F, Rabanales Sotos J y Simarro Herráez MJ. El estado de salud de las personas mayores que sufren insomnio. Gaceta Sanitaria, 2013. 27(1):47-52. 1.116 Q3
4 López-Torres Hidalgo, J., Simarro-Herráez, M., Rabanales-Sotos, J., Campos-Rosa, R., la-Ossa-Sendra, B. D., & Carrasco-Ortiz, C. Actitudes de los profesionales sanitarios de atención primaria hacia el cribado del cáncer colorrectal. Revista Española de Enfermedades Digestivas, 105(5), 272-278. 1.652 Q3
5 Hidalgo, J. L. T., Pretel, F. A., Bravo, B. N., Rabadan, F. E., Selva, J. P. S., Postigo, J. M. L., & Martínez, I. P. Training medical students about hazardous drinking using simple assessment techniques. Revista Española de Enfermedades Digestivas, 105(5), 272-278. 0.929 Q2
6 López-Torres Hidalgo, J. y grupo ANVITAD Efecto del calcio y la vitamina D en la reducción de caídas de las personas mayores: ensayo clínico aleatorizado frente a placebo.  Medicina Clínica. 1.399 Q2
7 Navarro B, López-Torres J, Andrés-Pretel F, Párraga I, Fernández de Peñaranda A, Gómez JD y Armero C. Advance directives from the point of view of the primary care physicians in Spain. Population Health Management (aceptado). 1.182 Q4
8 Artigao-Rodenas LM, Carbayo-Herencia JA, Divisón-Garrote JA, Gil-Guillén VF, Massó-Orozco J, Simarro-Rueda M,Molina-Escribano F, Sanchis C, Carrión-Valero L, López de Coca E, Caldevilla D, López-Abril J, Carratalá-Munuera C,Lopez-Pineda A; Grupo de Enfermedades Vasculares de Albacete (GEVA). Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern europe. PLoS One. 2013 Sep 5;8(9):e73529. 3.730 Q1
9 Puente KP, Hidalgo JL-T, Herráez MJS, Bravo BN, Rodríguez JO, Guillén VG. Study of the factors influencing the preparation of advance directives Archives of Gerontology and Geriatrics, 2014. 58:20-24. 1.704 Q3
10 Navarro B, Párraga I, López-Torres J, Andrés F y Rabanales J. Terapia cognitivo-conductual grupal para el tratamiento del insomnio: metaanálisis. Anales de Psicología (aceptado). 0.552 Q4
Cardiología
1 Córdoba-Soriano JG, Lamas-Oliveira C, Hidalgo-Olivares VM, Tercero-Martínez A, Barambio-Ruíz M, Salas-Nieto J. Valvular heart disease in hyperprolactinemic patients treated with low doses of cabergoline. Rev Esp Cardiol. 2013 May;66(5):410-2. 3.204 Q2
Cirugía
1 Honguero Martínez AF, Arnau Obrer A, Figueroa Almazán S, Martínez Hernández N, Guijarro Jorge R. Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer. Med Clin (Barc). 2013 Aug 12. 1.399 Q2
Dermatología
1 López-Villaescusa MT, Hernández-Martín A, Colmenero I, Torrelo A. Pityriasis Lichenoides in a 9-Month-Old Boy. Actas Dermosifiliogr. 2013 Oct 4.    
2 López-Villaescusa MT, Pérez-García LJ, Rodríguez-Vázquez M, Martínez-Martínez ML. Skin Toxicity Due to Telaprevir: A New Drug We Should Be Familiar With. Actas Dermosifiliogr. 2013 Jul 3.    
3 López-Villaescusa MT, Rodríguez-Vázquez M, Gómez-Sánchez ME, Vera Berón R. A patient with erythroderma desquamativa and eosinophilia. Semergen. 2013 May-Jun;39(4):242-3.    
4 López-Villaescusa MT, Pérez-García LJ, Martínez-Martínez ML, Faura-Berruga C. A patient with livedoid vasculitis. Semergen. 2013 Sep;39(6):340-1.    
5 Martínez-Martínez ML, Escario-Travesedo E, Nuñez-Ares A, Nam-Cha SH, Rodríguez-Vázquez M, Córdoba-Soriano JG, Sánchez-Simón-Talero R. Epoprostenol: flushing or erythroderma? Ann Dermatol. 2013 May;25(2):271-2. 0.611 Q4
6 López-Villaescusa MT, Martínez-Martínez ML, Faura-Berruga C, Gómez-Sánchez ME. Pustular lesions and fever. Med Clin (Barc). 2013 May 13;140(10):e19. 1.399 Q2
Endocrinología y Nutrición
1 Lamas Oliveira C. Metabolic consequences of craniopharyingioma and their management. Endocrinol Nutr. 2013 Mar 25.    
Geriatría
1 González-Vaca J, de la Rica-Escuín M, Silva-Iglesias M, Arjonilla-García MD, Varela-Pérez R, Oliver-Carbonell JL, Abizanda P. Frailty in INstitutionalized older adults from ALbacete. The FINAL Study: Rationale, design, methodology, prevalence and attributes. Maturitas. 2013 Oct 16. 2.844 Q2
2 Romero Rizos L, Abizanda Soler P. Frailty as a predictor of adverse events in epidemiological studies: Literature review. Rev Esp Geriatr Gerontol. 2013 Oct 1.    
3 Alfonso Silguero SA, Martínez-Reig M, Gómez Arnedo L, Juncos Martínez G, Romero Rizos L, Abizanda Soler P. Chronic disease, mortality and disability in an elderly Spanish population: The FRADEA study. Rev Esp Geriatr Gerontol. 2013 Sep 19.    
4 Abizanda P, Romero L, Sánchez-Jurado PM, Martínez-Reig M, Gómez-Arnedo L, Alfonso SA Frailty and mortality, disability and mobility loss in a Spanish cohort of older adults: the FRADEA study. Maturitas. 2013 Jan;74(1):54-60. 2.844 Q2
5 Abizanda Soler P.
Frailty: The new paradigm of health care in the elderly. Med Clin (Barc). 2013 Dec 19. 1.399 Q2
Unidad de Investigación
1 González-Masiá JA, García-Olmo D, García-Olmo DC. Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology. Onco Targets Ther. 2013 Jul 8;6:819-32. 2.073 Q3
2 García-Olmo DC, Picazo MG, Toboso I, Asensio AI, García-Olmo D. Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats. Mol Cancer. 2013 Feb 4;12:8. 5.134 Q1
3 García-Olmo DC, García-Olmo D. Biological role of cell-free nucleic acids in cancer: the theory of genometastasis. Crit Rev Oncog. 2013;18(1-2):153-61. Review.    
4 Solesio ME, Prime TA, Logan A, Murphy MP, Del Mar Arroyo-Jimenez M, Jordán J, Galindo MF. The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease. Biochim Biophys Acta. 2013 Jan;1832(1):174-82. 1.807 Q3
5 Solesio ME, Saez-Atienzar S, Jordan J, Galindo MF. 3-Nitropropionic acid induces autophagy by forming mitochondrial permeability transition pores rather than activating the mitochondrial fission pathway. Br J Pharmacol. 2013 Jan;168(1):63-75. 5.067 Q1
6 Carballosa-Gonzalez MM, Muñoz LJ, López-Alburquerque T, Pardal-Fernández JM, Nava E, de Cabo C, Sancho C, López DE. EEG characterization of audiogenic seizures in the hamster strain GASH:Sal. Epilepsy Res. 2013 Oct;106(3):318-25. 2.241 Q2
7 Pérez-Ortiz JM, García-Gutiérrez MS, Navarrete F, Giner S, Manzanares J Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims. Psychoneuroendocrinology. 2013 Aug;38(8):1251-8. 5.137 Q1
8 Ortega-Álvaro A, Ternianov A, Aracil-Fernández A, Navarrete F, García-Gutiérrez MS, Manzanares J. Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol. Addict Biol. 2013 Jul 16. 5.914 Q1
9 Ocaña A, Pandiella A. Targeting HER receptors in cancer. Curr Pharm Des. 2013;19(5):808-17. 3.311 Q1
10 Yu M, Ocana A, Tannock IF. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit? Cancer Metastasis Rev. 2013 Jun;32(1-2):211-27. 7.787 Q1
11 Vera-Badillo FE, Shapiro R, Ocana A, Amir E, Tannock IF. Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer. Ann Oncol. 2013 May;24(5):1238-44. 7.384 Q1
12 Ocana A, Seruga B, Amir E. Multidimensional challenges in clinical drug development, regulatory approval, and marketing. J Clin Oncol. 2013 Mar 20;31(9):1252-3. 18.038 Q1
13 Al-Mubarak M, Sacher AG, Ocana A, Vera-Badillo F, Seruga B, Amir E. Fulvestrant for advanced breast cancer: a meta-analysis. Cancer Treat Rev. 2013 Nov;39(7):753-8. 6.024 Q1
14 Ocana A, Amir E, Vera-Badillo F, Seruga B, Tannock IF. Phase III trials of targeted anticancer therapies: redesigning the concept. Clin Cancer Res. 2013 Sep 15;19(18):4931-40. 7.837 Q1
15 Ocaña A, Amir E, Seruga B, Martin M, Pandiella A. The evolving landscape of protein kinases in breast cancer: clinical implications. Cancer Treat Rev. 2013 Feb;39(1):68-76. 6.024 Q1
16 Ocana A, Vera-Badillo F, Seruga B, Templeton A, Pandiella A, Amir E. HER3 overexpression and survival in solid tumors: a meta-analysis. J Natl Cancer Inst. 2013 Feb 20;105(4):266-73. 14.336 Q1
17 Francisco E. Vera Badillo, Arnoud J. Templeton,Paulo de Gouveia, Iván Díaz-Padilla, Philippe L. Bedard, Mustafa Al-Mubarak, Bostjan Seruga, Ian F. Tannock, Alberto Ocaña, Eitan Amir Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis. Cancer Spectrum Knowledge Environment 11/2013 14.07 Q1
18 Ocaña A, Freedman O, Amir E, Seruga B, Pandiella A. Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors. Cancer Metastasis Rev. 2013 Dec 15. 7.787 Q1
Maxilofacial
1 García de Marcos JA, Heras Rincón I, González Córcoles C, Sebastián Alfaro M, Poblet Martínez E, Arroyo Rodríguez S. Bilateral Reverse Yu Flap for Upper Lip Reconstruction After Oncologic Resection. Dermatol Surg. 2013 Aug 5. 1.866 Q2
2 García-de Marcos JA, Pérez-Zafrilla B, Arriaga A, Arroyo-Rodríguez S, Poblet E. Human papillomavirus in carcinomas of the tongue: clinical and prognostic implications. Int J Oral Maxillofac Surg. 2013 Nov 19. 1.521 Q2
Medicina Interna
1 Sedano Casas A, Gato Díez A, Mora Escudero I, García Ángel RD. Cholesterol emboli-induced ischemic colitis. Med Clin (Barc). 2013 Aug 17;141(4):e7. 1.399 Q2
2 Solís-García del Pozo J, Gómez-Pérez I. The application of do not resuscitate orders and withholding treatment in patients admitted to Internal Medicine in a first level hospital. Rev Calid Asist. 2013 Jan;28(1):50-5.    
3 Rodríguez García JL, Khamashta MA. Clinical advances of interest in the diagnosis and treatment of patients with antiphospholipid syndrome. Rev Clin Esp. 2013 Mar;213(2):108-13.    
4 Cano-Cuenca N, Solís-García Del Pozo JE, Jordán J. Evidence for the Efficacy of Latrepirdine (Dimebon) Treatment for Improvement of Cognitive Function: A Meta-Analysis. J Alzheimers Dis. 2013 Aug 2. 4.174 Q2
5 Picazo DR, Villaescusa JR, Martínez EP, Pérez FD. Late collapse osteoporotic vertebral fracture in an elderly patient with neurological compromise. Eur Spine J. 2013 Jun 19. 2.133 Q2
6 Solís-García del Pozo J, Mínguez-Mínguez S, de Groot PW, Jordán J. Rasagiline meta-analysis: a spotlight on clinical safety and adverse events when treating Parkinson's disease. Expert Opin Drug Saf. 2013 Jul;12(4):479-86. 2.621 Q2
7 Porcel JM, Esquerda A, Vives M, Bielsa S. Etiology of Pleural Effusions: Analysis of More than 3,000 Consecutive Thoracenteses. Arch Bronconeumol. 2013 Dec 19 1.372 Q4
Nefrología
1 Martínez Fernández G, Ortega Cerrato A, Masiá Mondéjar J, Pérez Rodríguez A, Llamas Fuentes F, Gómez Roldán C, Pérez-Martínez J. Efficacy of dialysis in peritoneal dialysis: utility of bioimpedance to calculate Kt/V and the search for a target Kt. Clin Exp Nephrol. 2013 Apr;17(2):261-7. 1.246 Q4
Neurocirugía
1 Ramos AA, Vega MA, Valencia HS, García JC, Perez VC. Intraparenchymal schwannoma involving the brainstem in a young woman. Pediatr Neurol. 2013 Jun;48(6):472-4. 1.416 Q2
Neumología
1 Martínez-Moratalla J, Almar E, Antó JM. Changes in asthma treatment in the Spanish Cohort of the European Community Respiratory Health Survey (ECRHS) from 1991-2001: a perspective over time. Arch Bronconeumol. 2013 Mar;49(3):113-8. 1.372 Q4
Neurofisiología
1 Pardal-Fernández JM, Arciniegas A, Mansilla-López D, Sánchez-Iniesta R, Gutiérrez-Rubio JM. A new case of the absence of N20 at early cerebral anoxia-ischemia evaluation by somatosensory evoked potentials. Med Intensiva. 2013 Jan 19. 1.323 Q4
2 Pardal-Fernández JM, Martínez-Martínez ML, Escario-Travesedo E, Rodríguez-Vázquez M. Lumbar radiculopathy associated with focal denervation hyperhidrosis. Rev Neurol (Paris). 2013 Nov 18. 1.179 Q4
Neurología
1 Monteagudo M, Doménech C, Segura T. Terson syndrome and ocular ultrasound. Neurologia. 2013 Feb 28. 1.322 Q3
2 García-García J, Ayo-Martín O, Segura T A case of giant cell arteritis presenting as thunderclap headache. Headache. 2013 Mar;53(3):546-7. 2.937 Q2
3 Rico-Santos M, Segura T. The value of ultrasounds in the detection of muscle fasciculation. Rev Neurol. 2013 Jun 1;56(11):589. Spanish. 1.179 Q4
4 Purroy F; Jiménez Caballero PE; Gorospe A; Torres MJ; Alvarez-Sabin J; Santamaria E; Martinez-Sanchez P;
Cánovas D; Egido JA; Ramírez-Moreno JM; Alonso-Arias A; Rodríguez-Campello A; Casado I; Delgado-Mederos R; Martí-Fàbregas J; Fuentes B; Silva Y; Quesada H; Cardona P; Morales A; de la Ossa NP; García-Pastor A; Arenillas JF; Segura T; Jiménez C; Masjuan J.
Recurrent transient ischaemic attack and early risk of stroke:data from the PROMAPA study. Journal of Neurology, Neurosurgery & Psychiatry. 23/01/2013 4.924 Q1
5 Jiménez-Caballero PE; Coloma Navarro R; Ayo-Martin O; Segura T. Cerebral hemodynamic changes in obstructive sleep apnea syndrome after continous positive airway pressure treatment. Sleep Breath. 06/02/2013. 2.256 Q2
6 García-García J,; Ayo-Martín O; Segura T Is it justified to exclude patients with minor stroke from intravenous thrombolysis?. Int J Stroke. 8 - 3, 08/04/2013. 2.748 Q2
7 Palazón-García E; Ayo-Martín Ó; García-García J,; Segura T. Optic nerve head drusen Rev Neurol. 56 - 8, pp.
447. 16/04/2013.
1.179 Q4
8 López Fernández JC, Masjuan Vallejo J, Arenillas Lara J, Blanco González M, Botia Paniagua E, Casado; Naranjo
I, Deyá Arbona E, Escribano Soriano B, Freijo Guerrero MM, Fuentes B, Gállego Cullere J,; Geffners Sclarskyi D, Gil Núñez A, Gómez Escalonilla C, Lago Martin A, Legarda Ramírez I,;Maciñeiras Montero JL, MaestreMoreno J, Moniche Álvarez F, Muñoz Arrondo R, Purroy García F,; Ramírez Moreno JM, Rebollo Álvarez AmandixM, Roquer J, Rubio Borrego F, Segura T; Serrano Ponza M, Tejada García J, Tejero Juste C, Vidal Sánchez JA
Analysis of stroke care resources in Spain in 2012: Have we benefitted from the Spanish Health System's stroke care strategy? Neurología. S0213 - 13, pp. 163. 10/09/2013. 1.322 Q3
9 Segura T, Ayo-Martín O, Gómez-Fernandez I, Andrés C, Barba MA, Vivancos J. Cerebral hemodynamics and endothelial function in patients with Fabry disease BMC Neurology. 13 - 1, pp. 170. 11/11/2013. 2.564 Q2
Obstetricia y Ginecología
1 Álvarez C, García-Garrido C, Taronger R, González de Merlo G. In vitro maturation, fertilization, embryo development & clinical outcome of human metaphase-I oocytes retrieved from stimulated intracytoplasmic sperm injection cycles. Indian J Med Res. 2013 Feb;137(2):331-8. 2.061 Q2
2 Moreno Selva RD, Ruiz Sánchez ME, Losa Pajares EM, Gil Martínez-Acacio L, Galán Ros J, González de Merlo G. Puerperal meningitis by group B streptococcus. Med Clin (Barc). 2013 Dec 19. 1.399 Q2
3 Nogueira J, de Los Llanos Moreno R, Sánchez JM, González G. Chimeric disorders of sex development ovotesticular. Med Clin (Barc). 2013 Nov 25. 1.399 Q2
Oftalmología
1 Montero JA, Merino-Iglesias AA, Pérez-Martín S, Ruiz-Moreno JM. Intravitreal drug dispersion and needle gauge. Acta Ophthalmol. 2013 Jul 26. 2.345 Q2
2 Montero JA, Ruiz-Moreno JM, Sanchis-Merino ME, Perez-Martin S. Reply Retina. 2013 Jul 18. 2.825  
3 Copete-Piqueras S, Cava-Valenciano C, Flores-Moreno I, Moreno-Valladares A, Bautista Ruescas V. Antiangiogenic therapy in Sorsby's fundus dystrophy without a mutation in the TIMP-3 gene. Arch Soc Esp Oftalmol. 2013 Jun;88(6):240-3.    
4 López-Garrido MP, Medina-Trillo C, Morales-Fernandez L, Garcia-Feijoo J, Martínez-de-la-Casa JM, García-Antón M, Escribano J. Null CYP1B1 genotypes in primary congenital and nondominant juvenile glaucoma. Ophthalmology. 2013 Apr;120(4):716-23. 5.563 Q1
5 Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Fernández I, García-Gutiérrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon Y, Harsum S, Maclaren RE, Charteris D, Vanmeurs JC, González-Sarmiento R, Pastor JC; Genetics on PVR Study Group. The T309G MDM2 Gene Polymorphism Is a Novel Risk Factor for Proliferative Vitreoretinopathy. PLoS One. 2013 Dec 9;8(12) 3.730 Q1
Oncología
1 Balañá C, Vaz MA, Lopez D, de la Peñas R, García-Bueno JM, Molina-Garrido MJ, Sepúlveda JM, Cano JM, Bugés C, Sanz SM, Arranz JL, Perez-Segura P, Rodriguez A, Martin JM, Benavides M, Gil M. Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain. Clin Transl Oncol. 2013 Jun 21. 1.276 Q4
2 Kamieniak MM, Muñoz-Repeto I, Rico D, Osorio A, Urioste M, García-Donas J, Hernando S, Robles-Díaz L, Ramón Y Cajal T, Cazorla A, Sáez R, García-Bueno JM, Domingo S, Borrego S, Palacios J, van de Wiel MA, Ylstra B, Benítez J, García MJ. DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas. Br J Cancer. 2013 Apr 30;108(8):1732-42. 5.082 Q1
Pediatría
1 Carrascosa-Romero MC, Ruiz-Cano R, Martínez-López F, Alfaro-Ponce B, Pérez-Pardo A. Congenital mydriasis as an initial sign of septo-optic dysplasia. Arch Soc Esp Oftalmol. 2013 Oct;88(10):398-402.    
2 Carrascosa-Romero MC, Suela J, Pardal-Fernández JM, Bermejo-Sánchez E, Vidal-Company A, MacDonald A, Tébar-Gil R, Martínez-Fernández ML, Martínez-Frías ML. A 2.84 Mb deletion at 21q22.11 in a patient clinically diagnosed with Marden-Walker syndrome. Am J Med Genet A. 2013 Sep;161(9):2281-90. 2.304 Q3
3 Hoyos Vázquez MS, Vidal Company A, Fernández Córdoba MS, Gonzálvez Piñera J, García Castillo S. Anterior urethral valves in the navicular fossa. A rare cause of renal failure. An Pediatr (Barc). 2013 Jun 13. 0.867 Q3
4 Alcaraz AJ, Gil-Ruiz MA, Castillo A, López J, Romero C, Fernández SN, Carrillo A. Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts Acute Kidney Injury After Pediatric Cardiac Surgery. Pediatr Crit Care Med. 2013 Dec 20. 2.354 Q1
Radiodiagnóstico
1 Palma Baro A, Caldevilla Bernardo D, Parrondo Muiños C. Mesenteric ischemia: Update of new diagnostic techniques for an old disease, and review of radiological signs. Semergen. 2013 Jul-Aug;39(5):279-81.    
Radioterapia
1 Sabater S, Sevillano MM, Andres I, Berenguer R, Machin-Hamalainen S, Müller K, Arenas M. Reduction of rectal doses by removal of gas in the rectum during vaginal cuff brachytherapy. Strahlenther Onkol. 2013 Sep 4. 4.163 Q1
Urología
1 Peran Teruel M, Fernandez Anguita PJ, Martinez Ruiz J, Nuñez Sarrion MA, Gimenez Bachs JM, Virseda Rodriguez J. Giant angiomyolipoma in the upper pole of the right kidney. Arch Esp Urol. 2013 Oct;66(8):828-829.    
2 Pastor Navarro H, Martinez Ruiz J, Martinez Sanchiz C, Peran Teruel M, Segura Martin M, Pastor Guzman JM, Virseda Rodriguez J. Paraurethral Leiomyoma. Arch Esp Urol. 2013 Oct;66(8):820-823.    

* FI: Factor de Impacto

 

  Subir

 

 


2012





2011


2010

 

Pie de página

Complejo Hospitalario Universitario de Albacete. Webmaster. Todos los derechos reservados. Nota Legal.


HTML 4.01 Transitional válido - CSS Válido - Icono de conformidad con el Nivel Triple-A, de las Directrices de Accesibilidad para el 	Contenido Web 1.0 del W3C-WAI - Validado por TAW